Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032

Overview

The Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market is expected to reach a 121.19 USD Million by 2032 and is projected to grow at a CAGR of 13.22% from 2025 to 2032.

Revenue, 2024 (USD Million)
57.46
Forecast, 2032 (USD Million)
121.19
CAGR, 2024 - 2032
13.22%
Report Coverage
Thailand

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market 2018-2032 USD Million

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 57.46 USD Million
  • Projected Market Size (2032): 121.19 USD Million
  • CAGR (2025-2032): 13.22%

Key Findings of Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market

  • The Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at 57.46 USD Million in 2024.
  • The Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market is likely to grow at a CAGR of 13.22% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Parenteral in Route of Administration Segment accounted for the largest share of the market with a revenue of 41.89 USD Million
  • The fastest growing segment Inhalation of Harmful Substances in Cause Segment grew Fastest with a CAGR of 14.01% during the forecast period from 2024 to 2032.

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segmentation & Scope
Distribution Channel
  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
  • Direct Tender
End User
  • Others
  • Home Healthcare
  • Specialty Clinics
  • Hospitals
Type
  • Others
  • Tocilizumab
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Antiviral Medication
  • Corticosteroids
  • Mechanical Ventilation
Cause
  • Others
  • Severe Pneumonia
  • Inhalation of Harmful Substances
  • Sepsis
Route of Administration
  • Others
  • Oral
  • Parenteral

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Million
Market Value in 2024 57.46 USD Million
Market Value in 2032 121.19 USD Million
CAGR (2025-2032) 13.22%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,End User,Type,Cause ,Route of Administration

Regional Insights:

  • Leading Market (2024-2032): Thailand, leading in terms of revenue 57.46 USD Million in 2024
    • Key Country: Thailand, leading in terms of revenue with value of 57.46 USD Million in 2024.

Segments and Scope

  • Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 32.69 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.93 % in forecast period 2025-2032.
  • Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By End User
    • Hospitals is the largest segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 39.69 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.48 % in forecast period 2025-2032.
  • Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Type
    • Mechanical Ventilation is the largest segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 26.82 USD Million in the year 2024.
    • Mechanical Ventilation is the Fastest growing segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 14.00 % in forecast period 2025-2032.
  • Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Cause
    • Sepsis is the largest segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 33.01 USD Million in the year 2024.
    • Inhalation of Harmful Substances is the Fastest growing segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.58 % in forecast period 2025-2032.
  • Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Route of Administration
    • Parenteral is the largest segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 41.89 USD Million in the year 2024.
    • Parenteral is the Fastest growing segment in Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.64 % in forecast period 2025-2032.

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Share Analysis

 
Company Name Company Share Analysis
Medtronic
LivaNova
Terumo Corporation
Getinge AB
Gilead Sciences, Inc.
Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Share Analysis

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Geographical Sales Distribution, 2018-2032 USD Million

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Geographical Sales Distribution, 2018-2032 USD Million

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling
Frequently Asked Questions
The Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation Distribution Channel,End User,Type,Cause ,Route of Administration .
Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 57.46(Revenue in USD Million) in 2021.
Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 13.22% during the forecast period of 2024 to 2032.
The Parenteral segment is expected to dominate the Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market, holding a largest market share of 41.89 USD Million in 2024

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segmentation & Scope
Distribution Channel
  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
  • Direct Tender
End User
  • Others
  • Home Healthcare
  • Specialty Clinics
  • Hospitals
Type
  • Others
  • Tocilizumab
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Antiviral Medication
  • Corticosteroids
  • Mechanical Ventilation
Cause
  • Others
  • Severe Pneumonia
  • Inhalation of Harmful Substances
  • Sepsis
Route of Administration
  • Others
  • Oral
  • Parenteral
Frequently Asked Questions
The Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation Distribution Channel,End User,Type,Cause ,Route of Administration .
Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 57.46(Revenue in USD Million) in 2021.
Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 13.22% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market for final year is USD 121.19 (USD Million).

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling

Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling
Frequently Asked Questions
The Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation Distribution Channel,End User,Type,Cause ,Route of Administration .
Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 57.46(Revenue in USD Million) in 2021.
Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 13.22% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Acute Respiratory Distress Syndrome (ARDS) Treatment Market for final year is USD 121.19 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.